Cyclooxygenase products and atherosclerosis

This publication has 112 references indexed in Scilit:

• Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells
  Biochemical and Biophysical Research Communications, 2006
• Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
  Proceedings of the National Academy of Sciences, 2006
• Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
  Journal of Clinical Investigation, 2006
• Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
  Journal of Clinical Investigation, 2005
• Prostacyclin protects against elevated blood pressure and cardiac fibrosis
  Cell Metabolism, 2005
• Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
  New England Journal of Medicine, 2005
• Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With Hypertension
  Hypertension, 2003
• Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
  Journal of Clinical Investigation, 1999
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Prostaglandin endoperoxide synthase: structure and catalysis
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991